The table below shows Acumen Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$24.13M
-$34.12M
-$17.86M
-$10.18M
-$8.30M
-$2.37M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-$13.81M
$28.69M
-$9.20M
-$41.93M
-$5.10M
-
Dividends paid
-
-
-
-
ABOS operating cash flow (10-K history)
Acumen Pharmaceuticals, Inc. reported operating cash flow of -$115.54M for fiscal year 2025. That is down 34.0% from -$86.22M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$7.45M (FY 2020) to -$115.54M. Figures come from the company's audited annual reports as filed with the SEC.